A. Kearns
Molecular Biology · with Khosla · 2008
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 18 citations into it
- Oncology — 17 citations into it
Whom A. Kearns trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Kearns's perspective
Ordered by how strongly the researchers A. Kearns trusts endorse each paper. Same corpus, a different order for every researcher.
- TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. (Journal of Clinical Investigation)
- IL-1 mediates TNF-induced osteoclastogenesis. (Journal of Clinical Investigation)
- Denosumab in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
- Bone resorption by osteoclasts. (Science)
- Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. (Journal of Clinical Investigation)
- RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. (Proceedings of the National Academy of Sciences of the United States of America)
- Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. (Journal of Clinical Investigation)
- Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. (Developmental Cell)
- Distinct molecular mechanism for initiating TRAF6 signalling (Nature)
- T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ (Nature)